Newamsterdam Pharma Company N.V. Ordinary Shares reports a Return on Equity (ROE) of -31.98%.

What is NAMS's dividend yield?

Newamsterdam Pharma Company N.V. Ordinary Shares offers a dividend yield of 0.00%.

What is NAMS's Quality Score?

Our AI rates NAMS's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NAMS?

Our AI Timing Score for NAMS is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NAMS belong to?

Newamsterdam Pharma Company N.V. Ordinary Shares is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Newamsterdam Pharma Company N.V. (NAMS) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

NAMS AI Analysis Summary

Our AI summary for NAMS: Newamsterdam Pharma Company N.V. Ordinary Shares (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -31.98%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

NAMS

Newamsterdam Pharma Company N.V. Ordinary Shares

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 27.49

-0.30 (-1.08%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-32.0%

ROE

-29.0%

ROA

0.00%

Div Yield

NEWAMSTERDAM PHARMA COMPANY N.V. ORDINARY SHARES
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 27.49 Price -0.30 (-1.08%) Day Change	NEWS SCORE: 99

NAMS, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	27.49
PBV / Sector	4.88 / 44,219.29
Earning Per Share	-1.80

PE / Sector	N/A / 19.28
PEG or PE/Growth / Sector	N/A / 1.23
Average 1M Daily Value	28.15 M GREAT
Average 1W Daily Value	26.10 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-942.76 / 98.22
NPM Average (%) / Sector	-731.31 / -1,697.63
NPM Change Average (%) / Sector	1,403.68 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-29.04 / 185,260.96
ROA Average (%) / Sector	-27.84 / 36,684.70
ROA Change Average (%) / Sector	234.22 / 422,221.66 GREAT
ROE (%) / Sector	-31.98 / 243,762.23
ROE Average (%) / Sector	-32.06 / 48,758.47
ROE Change Average (%) / Sector	254.62 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

Registration Details

Analyze Date	2026-08-04 08:01:53
Symbol	NAMS
Name	NEWAMSTERDAM PHARMA COMPANY N.V. ORDINARY SHARES
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	116.90 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	3,248.76 / 9,645.64

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Gooimeer 2-35, Naarden, Netherlands, 1411 DC

Phone: 31 35 206 2971

Website: https://www.newamsterdampharma.com

Employees: 100

Sector: Healthcare >> Biotechnology

Description: NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.